[go: up one dir, main page]

NO20010860D0 - Nye forbindelser - Google Patents

Nye forbindelser

Info

Publication number
NO20010860D0
NO20010860D0 NO20010860A NO20010860A NO20010860D0 NO 20010860 D0 NO20010860 D0 NO 20010860D0 NO 20010860 A NO20010860 A NO 20010860A NO 20010860 A NO20010860 A NO 20010860A NO 20010860 D0 NO20010860 D0 NO 20010860D0
Authority
NO
Norway
Prior art keywords
new connections
connections
new
Prior art date
Application number
NO20010860A
Other languages
English (en)
Other versions
NO20010860L (no
Inventor
Amin Kosrat
Mikael Dahlstroem
Peter Nordberg
Ingemar Starke
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of NO20010860D0 publication Critical patent/NO20010860D0/no
Publication of NO20010860L publication Critical patent/NO20010860L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
NO20010860A 1998-08-21 2001-02-20 Nye forbindelser NO20010860L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9802794A SE9802794D0 (sv) 1998-08-21 1998-08-21 New compounds
PCT/SE1999/001402 WO2000011000A2 (en) 1998-08-21 1999-08-18 New compounds

Publications (2)

Publication Number Publication Date
NO20010860D0 true NO20010860D0 (no) 2001-02-20
NO20010860L NO20010860L (no) 2001-04-23

Family

ID=20412307

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20010860A NO20010860L (no) 1998-08-21 2001-02-20 Nye forbindelser

Country Status (20)

Country Link
US (3) US6579884B1 (no)
EP (2) EP1411056A3 (no)
JP (1) JP2002523415A (no)
KR (1) KR20010072798A (no)
CN (1) CN1329613A (no)
AR (1) AR020226A1 (no)
AT (1) ATE280768T1 (no)
AU (1) AU5767999A (no)
BR (1) BR9913103A (no)
CA (1) CA2339286A1 (no)
DE (1) DE69921483T2 (no)
DK (1) DK1105391T3 (no)
ES (1) ES2229763T3 (no)
IL (1) IL141166A0 (no)
NO (1) NO20010860L (no)
PT (1) PT1105391E (no)
SE (1) SE9802794D0 (no)
SI (1) SI1105391T1 (no)
WO (1) WO2000011000A2 (no)
ZA (1) ZA200100913B (no)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9802794D0 (sv) * 1998-08-21 1998-08-21 Astra Ab New compounds
SE0003186D0 (sv) * 2000-09-07 2000-09-07 Astrazeneca Ab New process
UA80393C2 (uk) 2000-12-07 2007-09-25 Алтана Фарма Аг Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці
SE0102808D0 (sv) * 2001-08-22 2001-08-22 Astrazeneca Ab New compounds
MY140561A (en) 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
NZ538595A (en) * 2002-09-19 2006-04-28 Schering Corp Pyrazolopyridines as cyclin dependent kinase (CDK) inhibitors useful in treating diseases such as cancer, leukemia, fibrosarcoma and glioma
MXPA05003058A (es) * 2002-09-19 2005-05-27 Schering Corp Nuevas imidazopiridinas como inhibidores de cinasa dependientes de ciclina.
KR101179012B1 (ko) 2003-03-10 2012-09-03 니코메드 게엠베하 로플루미라스트 신규한 제조 방법
SE0301904D0 (sv) 2003-06-26 2003-06-26 Astrazeneca Ab Novel imidazopyridine compound II with therapeutic effect
US8536492B2 (en) * 2003-10-27 2013-09-17 Applied Materials, Inc. Processing multilayer semiconductors with multiple heat sources
EP1974730A1 (en) 2003-11-03 2008-10-01 AstraZeneca AB Imidazo[1,2-a]pyridine derivatives for use in the treatment of sleep disturbance due to silent gastro-esophageal reflux
WO2005070927A2 (en) * 2004-01-26 2005-08-04 Altana Pharma Ag 1,2,4-triazolo[1,5-a] pyridines as gastric acid secretion inhibitors
KR20220084426A (ko) * 2004-07-28 2022-06-21 다케다 야쿠힌 고교 가부시키가이샤 피롤로〔2,3-c〕피리딘 화합물, 그 제조 방법 및 용도
EP1861074B1 (en) * 2005-03-16 2013-04-24 Takeda GmbH Taste masked dosage form containing roflumilast
US7951818B2 (en) 2006-12-01 2011-05-31 Galapagos Nv Imidazolopyridine compounds useful for the treatment of degenerative and inflammatory diseases
US20100267712A1 (en) * 2007-09-27 2010-10-21 The United States of America, as represented by the Secretary, Department of Health and Isoindoline compounds for the treatment of spinal muscular atrophy and other uses
KR101605063B1 (ko) 2009-07-09 2016-03-21 라퀄리아 파마 인코포레이티드 소화관 운동이상이 관여하는 질환의 치료용 산 펌프 길항제
CN111606846A (zh) * 2020-05-12 2020-09-01 广州理文科技有限公司 一种n`-三氟甲磺酰基n杂芳香胺类化合物及其制备方法
WO2025058459A1 (ko) * 2023-09-15 2025-03-20 (주)휴온스 신규한 이미다조피리딘계 화합물 및 이를 유효성분으로 포함하는 위장관 염증질환 또는 위산-관련 질환의 예방, 개선 또는 치료용 조성물

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA81219B (en) 1980-01-23 1982-01-27 Schering Corp Imidazo (1,2-a) pyridines ,process for their preparation and pharmaceutical compositions containing them
DE3269604D1 (en) * 1981-06-26 1986-04-10 Schering Corp Novel imidazo(1,2-a)pyridines and pyrazines, processes for their preparation and pharmaceutical compositions containing them
US4725601A (en) * 1985-06-04 1988-02-16 Fujisawa Pharmaceutical Co., Ltd. Certain imidazo[1,2-a]pyridines useful in the treatment of ulcers
US5574042A (en) 1992-11-02 1996-11-12 Fujisawa Pharmaceutical Co., Ltd Imidazo [1,2-a] pyridines and their pharmaceutical use
IL108520A (en) * 1993-02-15 1997-09-30 Byk Gulden Lomberg Chem Fab 2, 3, 8-TRISUBSTITUTED IMIDAZO £1, 2-a| PYRIDINE DERIVATIVES, PROCESSES FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
EP0695303B1 (de) 1993-04-22 2001-11-28 Byk Gulden Lomberg Chemische Fabrik GmbH Pyridiniumsalze und ihre verwendung zur bekämpfung von helicobacter-bakterien
UA48122C2 (uk) 1993-10-11 2002-08-15 Бік Гульден Ломберг Хеміше Фабрік Гмбх АЛКОКСІАЛКІЛКАРБАМАТИ ІМІДАЗО[1,2-а]ПІРИДИНІВ, СПОСІБ ЇХ ОДЕРЖАННЯ ТА ЛІКАРСЬКИЙ ЗАСІБ НА ЇХ ОСНОВІ
JPH10505333A (ja) 1994-07-28 1998-05-26 ビイク グルデン ロンベルク ヒェーミッシェ ファブリーク ゲゼルシャフト ミット ベシュレンクテル ハフツング イミダゾピリジン−アゾリジノン
CA2196076A1 (en) 1994-07-28 1996-02-08 Gerhard Grundler Acyl imidazopyridines
JPH10505330A (ja) 1994-07-28 1998-05-26 ビイク グルデン ロンベルク ヒェーミッシェ ファブリーク ゲゼルシャフト ミット ベシュレンクテル ハフツング ハロゲンイミダゾピリジン
WO1996003403A1 (de) 1994-07-28 1996-02-08 Byk Gulden Lomberg Chemische Fabrik Gmbh Benzylimidazopyridine
DE59712297D1 (de) 1996-01-26 2005-06-09 Altana Pharma Ag 3-alkylimidazopyridine
DE19602853A1 (de) 1996-01-26 1997-07-31 Byk Gulden Lomberg Chem Fab Neue Halogenimidazopyridine
SE9700661D0 (sv) * 1997-02-25 1997-02-25 Astra Ab New compounds
SE9801526D0 (sv) * 1998-04-29 1998-04-29 Astra Ab New compounds
SE9802794D0 (sv) * 1998-08-21 1998-08-21 Astra Ab New compounds
SE9802793D0 (sv) * 1998-08-21 1998-08-21 Astra Ab New compounds

Also Published As

Publication number Publication date
DE69921483T2 (de) 2006-02-02
ZA200100913B (en) 2002-05-02
AR020226A1 (es) 2002-05-02
EP1105391A2 (en) 2001-06-13
SE9802794D0 (sv) 1998-08-21
US20030220364A1 (en) 2003-11-27
PT1105391E (pt) 2005-01-31
EP1411056A2 (en) 2004-04-21
SI1105391T1 (en) 2005-02-28
CN1329613A (zh) 2002-01-02
US6579884B1 (en) 2003-06-17
BR9913103A (pt) 2001-05-08
NO20010860L (no) 2001-04-23
WO2000011000A2 (en) 2000-03-02
US6790960B2 (en) 2004-09-14
JP2002523415A (ja) 2002-07-30
EP1105391B1 (en) 2004-10-27
WO2000011000A3 (en) 2000-06-15
ES2229763T3 (es) 2005-04-16
EP1411056A3 (en) 2004-04-28
US20050154007A1 (en) 2005-07-14
KR20010072798A (ko) 2001-07-31
CA2339286A1 (en) 2000-03-02
DK1105391T3 (da) 2005-01-24
DE69921483D1 (de) 2004-12-02
ATE280768T1 (de) 2004-11-15
IL141166A0 (en) 2002-02-10
AU5767999A (en) 2000-03-14

Similar Documents

Publication Publication Date Title
NO20000312D0 (no) Nye forbindelser
NO20014518D0 (no) Nye forbindelser
DK1202994T3 (da) Nye forbindelser
NO20002787D0 (no) Nye forbindelser
NO20021436D0 (no) Nye forbindelser
NO20005832L (no) Nye spesielle formuleringer
NO20003347D0 (no) Nye macrolider
NO20001938D0 (no) Nye aryloksy-alkyl-dialkylaminer
NO20020810D0 (no) Nye fenylpiperaziner
ID23287A (id) Trisiklik tersubstitusi
NO20015383D0 (no) Nye forbindelser
EP1124578A4 (en) NEW IMMUNOADJUVANTS
NO20010860D0 (no) Nye forbindelser
DK0906288T3 (da) Nye forbindelser
NO20010861D0 (no) Nye forbindelser
ID23219A (id) Trisiklik tersubstitusi
NO20005857D0 (no) Nye blandinger
NO20015374L (no) Nye forbindelser
NO995945D0 (no) Nye forbindelser
NO20010584L (no) Nye forbindelser
NO20011262L (no) Nye forbindelser
NO20014629D0 (no) Nye forbindelser
NO990072D0 (no) Nye forbindelser
DE59911610D1 (de) Substituierte benzoylcyclohexandione
NO20016273D0 (no) Nye forbindelser

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application